EurekAlert!

Optical genome mapping detects additional genetic variants in nearly 20% of individuals with acute leukemia

A study in The Journal of Molecular Diagnostics assessing the efficacy of optical genome mapping (OGM) in a cohort of patients with acute leukemia has demonstrated that OGM provided reliable and ...
EurekAlert!

Technical Validation and Prospective Clinical Utility of Optical Genome Mapping in Acute Leukemia Workup: Insights from 200 Cases following Deployment as a First-Line ...

A study in The Journal of Molecular Diagnostics assessing the efficacy of optical genome mapping (OGM) in a cohort of patients with acute leukemia has demonstrated that OGM provided reliable and ...
Seeking Alpha

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy

SAN DIEGO, June 18, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (BNGO) recently participated in the European Society of Human Genetics (ESHG) conference held in Milan, Italy, from May 24-27, 2025. The ...
GEN

BGI to Push OpGen’s Optical Mapping for Whole-Genome Assembly

Technology bridges strain typing and sequencing to correlate phenotype to genotype. Beijing Genomics Institute (BGI) and OpGen have decided to work together to expand the use of the latter’s Optical ...
Nasdaq

Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025

SAN DIEGO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the Association for Molecular Pathology (AMP) Annual Meeting, held November 11-15, 2025 in Boston, MA. Key ...
Seeking Alpha

International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in ...

SAN DIEGO, May 02, 2025 (GLOBE NEWSWIRE) -- Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (BNGO) that offers CLIA-certified laboratory developed tests (LDTs) based on ...